- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 62.9M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $53.38M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $53.31M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $45K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $13.37M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $11.35M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $33.18M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $34.93M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $100.51M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $104.2M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $149.44M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $161.4M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $205.85M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $217.09M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 61.79M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $3.93M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$7.22M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $126.39M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $137.94M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.30 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.30 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $14.36M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $5.26M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$18.68M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$18.97M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $40.98M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $10.13M |
| Revenue | Q1 2025 · Mar 31, 2024 | $51.11M |